• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, March 17, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Survey: Australians lack awareness of UV risk to eye health

by Staff Writer
June 3, 2019
in Company updates & acquisitions
Reading Time: 3 mins read
A A
Share on FacebookShare on Twitter

According to a national survey conducted by Carl Zeiss Australia, many Australians do not recognise the full effect UV light has on eyes.In findings that the company described as “alarming”, its recently published MyEyeQ Report found that 73% of respondents were unaware most eye-related UV damage happened before the age of 18, and 45% were not aware of the level of UV protection their sunglasses provided.Additionally, 71% of spectacle wearers did not know the level of UV protection their lenses offered.According to Carl Zeiss Australia, unsubstantiated concerns about blue light risk and a lack of understanding regarding protection levels could be preventing consumers from fully comprehending the risks of UV light.According to the survey results, 62% of parents found it difficult to understand the UV protection levels displayed on children’s sunglasses.“To some degree, the blue light conversation has eclipsed UV concerns. While the media has latched on to blue light, there is no firm clinical evidence to suggest that blue light from digital devices poses a health risk anywhere close to that of UV,” Ms Hilke Fitzsimons, Carl Zeiss Australia general manager said.{{quote-A:R-W:400-I:2-Q:“Australians recognise they need to protect their eyes, but they are underestimating the risks and are confused by what they see on the shelves and hear in the media.” -who:Hilke Fitzsimons, Carl Zeiss Australia}}“Australians recognise they need to protect their eyes, but they are underestimating the risks and are confused by what they see on the shelves and hear in the media. The industry has an important role to play in consumer education and purchase behaviour.”Fitzsimons said that in some cases product labelling could be misleading. For example, some companies claim ‘full UV protection’ on lenses that only protect from light up to 380nm. To achieve full UV protection, lenses need to withstand up to 400nm.“People are also confused by the distinction between things like UV protection and polarisation. Polarisation eliminates glare and can be more comfortable for the eyes but does not offer any additional UV protection,” she said.The survey also stated that while 66% of Australians will develop skin cancer by the age of 70, some were not aware the eyelid region was one of the most common sites for nonmelanoma skin cancers.Despite this risk, 33% of respondents indicated they were more concerned about protecting their skin from sun damage than their eyes, while almost half of Australians were only “somewhat concerned” about the risk of eye damage from UV light.“We are fed so much information these days about skin anti-aging and sun damage, but it’s important people understand our eyes face the same risks, and the damage begins early,” Fitzsimons said.“Photoaging of the skin around the eyes, several cancers on the skin around the eye and within the eye, cataracts, macular degeneration and preventable blindness are among the consequences of UV exposure. Consumers need to take this information very seriously.”The survey involved 1,000 participants from across Australia. IMAGE GALLERY


{{image3-a:l-w:960}} More reading:Sunglasses standard to be mandatory from 2019 

Related Posts

Dr Michele Ginocchietti. Image: EssilorLuxottica

Global executive appointed to lead EssilorLuxottica in ANZ

by Staff Writer
March 12, 2026

Dr Michele Ginocchietti has been appointed head of ANZ at EssilorLuxottica, bringing more than a decade of experience within the...

Image: Andrii Yalanskyi/stock.adobe.com.

People on the move – March 2026

by Staff Writer
March 10, 2026

Welcome to People on the move – March 2026, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and...

The Glaukos team has celebrated 10 years in Australia. Image: Glaukos.

Glaukos Australia celebrates 10-year anniversary, 3 million implants worldwide

by Rob Mitchell
March 9, 2026

Glaukos Australia has celebrated its 10-year anniversary, marking a decade of advancing glaucoma care across the country. This milestone coincides with...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited